Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 193

1.

The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc.

Li J, Kretzner L.

Mol Cell Biochem. 2003 Aug;250(1-2):91-105.

PMID:
12962147
[PubMed - indexed for MEDLINE]
2.

Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells.

Cetinkaya C, Hultquist A, Su Y, Wu S, Bahram F, PĂ„hlman S, Guzhova I, Larsson LG.

Mol Cancer Ther. 2007 Oct;6(10):2634-41.

PMID:
17938259
[PubMed - indexed for MEDLINE]
Free Article
3.

Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on the core promoter region.

Zhang J, Chen S, Zhang W, Zhang J, Liu X, Shi H, Che H, Wang W, Li F, Yao L.

Gene. 2008 Jul 1;417(1-2):5-12. doi: 10.1016/j.gene.2008.03.002. Epub 2008 Mar 12.

PMID:
18455888
[PubMed - indexed for MEDLINE]
4.

Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.

Cohn SL, Salwen H, Quasney MW, Ikegaki N, Cowan JM, Herst CV, Kennett RH, Rosen ST, DiGiuseppe JA, Brodeur GM.

Oncogene. 1990 Dec;5(12):1821-7.

PMID:
2284101
[PubMed - indexed for MEDLINE]
5.

Low NDRG1 mRNA expression predicts a poor prognosis in neuroblastoma patients.

Matsushita K, Uchida K, Saigusa S, Ide S, Hashimoto K, Koike Y, Otake K, Inoue M, Tanaka K, Kusunoki M.

Pediatr Surg Int. 2013 Apr;29(4):363-8. doi: 10.1007/s00383-012-3248-6.

PMID:
23296375
[PubMed - indexed for MEDLINE]
6.

Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features.

Tajiri T, Liu X, Thompson PM, Tanaka S, Suita S, Zhao H, Maris JM, Prendergast GC, Hogarty MD.

Clin Cancer Res. 2003 Aug 15;9(9):3345-55.

PMID:
12960121
[PubMed - indexed for MEDLINE]
Free Article
7.

Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma.

Chua MS, Sun H, Cheung ST, Mason V, Higgins J, Ross DT, Fan ST, So S.

Mod Pathol. 2007 Jan;20(1):76-83. Epub 2006 Sep 29.

PMID:
17170744
[PubMed - indexed for MEDLINE]
Free Article
8.

Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo.

Said HM, Stein S, Hagemann C, Polat B, Staab A, Anacker J, Schoemig B, Theobald M, Flentje M, Vordermark D.

Oncol Rep. 2009 Jan;21(1):237-46.

PMID:
19082468
[PubMed - indexed for MEDLINE]
9.

Nestin is a potential mediator of malignancy in human neuroblastoma cells.

Thomas SK, Messam CA, Spengler BA, Biedler JL, Ross RA.

J Biol Chem. 2004 Jul 2;279(27):27994-9. Epub 2004 Apr 26.

PMID:
15117961
[PubMed - indexed for MEDLINE]
Free Article
10.

Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma.

Manohar CF, Salwen HR, Brodeur GM, Cohn SL.

Genes Chromosomes Cancer. 1995 Nov;14(3):196-203.

PMID:
8589036
[PubMed - indexed for MEDLINE]
11.

NDRG1 is necessary for p53-dependent apoptosis.

Stein S, Thomas EK, Herzog B, Westfall MD, Rocheleau JV, Jackson RS 2nd, Wang M, Liang P.

J Biol Chem. 2004 Nov 19;279(47):48930-40. Epub 2004 Sep 17.

PMID:
15377670
[PubMed - indexed for MEDLINE]
Free Article
12.

NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number.

Woo CW, Lucarelli E, Thiele CJ.

Oncogene. 2004 Feb 26;23(8):1522-30.

PMID:
14691455
[PubMed - indexed for MEDLINE]
13.

Down-regulation of NDRG1 promotes migration of cancer cells during reoxygenation.

Lai LC, Su YY, Chen KC, Tsai MH, Sher YP, Lu TP, Lee CY, Chuang EY.

PLoS One. 2011;6(8):e24375. doi: 10.1371/journal.pone.0024375. Epub 2011 Aug 30.

PMID:
21912630
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

N-MYC regulates focal adhesion kinase expression in human neuroblastoma.

Beierle EA, Trujillo A, Nagaram A, Kurenova EV, Finch R, Ma X, Vella J, Cance WG, Golubovskaya VM.

J Biol Chem. 2007 Apr 27;282(17):12503-16. Epub 2007 Feb 27.

PMID:
17327229
[PubMed - indexed for MEDLINE]
Free Article
15.

Direct recruitment of N-myc to target gene promoters.

Mac SM, D'Cunha CA, Farnham PJ.

Mol Carcinog. 2000 Oct;29(2):76-86.

PMID:
11074604
[PubMed - indexed for MEDLINE]
16.

N-myc modulates expression of p73 in neuroblastoma.

Zhu X, Wimmer K, Kuick R, Lamb BJ, Motyka S, Jasty R, Castle VP, Hanash SM.

Neoplasia. 2002 Sep-Oct;4(5):432-9.

PMID:
12192602
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells.

Valsesia-Wittmann S, Magdeleine M, Dupasquier S, Garin E, Jallas AC, Combaret V, Krause A, Leissner P, Puisieux A.

Cancer Cell. 2004 Dec;6(6):625-30.

PMID:
15607966
[PubMed - indexed for MEDLINE]
Free Article
18.

Human neuroblastoma cell lines that express N-myc without gene amplification.

Wada RK, Seeger RC, Brodeur GM, Einhorn PA, Rayner SA, Tomayko MM, Reynolds CP.

Cancer. 1993 Dec 1;72(11):3346-54.

PMID:
8242562
[PubMed - indexed for MEDLINE]
19.

Involvement of Myc targets in c-myc and N-myc induced human tumors.

Ben-Yosef T, Yanuka O, Halle D, Benvenisty N.

Oncogene. 1998 Jul 16;17(2):165-71.

PMID:
9674700
[PubMed - indexed for MEDLINE]
Free Article
20.

Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.

Krajewski S, Chatten J, Hanada M, Reed JC.

Lab Invest. 1995 Jan;72(1):42-54.

PMID:
7837790
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk